Marolac

Marolac

ketorolac

Manufacturer:

ACME

Distributor:

D'Conner Pharma

Marketer:

Euro Generics
Concise Prescribing Info
Contents
Ketorolac trometamol
Indications/Uses
Short-term management of moderate to severe post-op pain.
Dosage/Direction for Use
Adult & childn >16 yr Initially 10 mg by IM or IV inj over at least 15 sec, then 10-30 mg 4-6 hrly (up to 2 hrly during initial post-op period). Max: 90 mg daily. Elderly & patient weighing <50 kg Max: 60 mg daily. Max duration of treatment: 2 days.
Contraindications
Hypersensitivity to ketorolac tromethamine & other NSAIDs. History of PUD or GI bleeding, asthma. Suspected or confirmed cerebrovascular bleeding, hemorrhagic diatheses including coagulation disorders. Pregnancy & lactation. Childn <16 yr.
Special Precautions
Monitor for signs of serious GI adverse events.
Adverse Reactions
Nausea, dyspepsia, GI pain, dizziness, headache, sweating, dry mouth, bradycardia, purpura, thrombocytopenia, dyspnea, asthma, pruritus, urticaria, anaphylaxis, bronchospasm.
Drug Interactions
Methotrexate, diuretics, ACE inhibitors, warfarin, lithium, aminoglycosides & other NSAIDs.
MIMS Class
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
ATC Classification
M01AB15 - ketorolac ; Belongs to the class of acetic acid derivatives and related substances of non-steroidal antiinflammatory and antirheumatic products.
Presentation/Packing
Form
Marolac soln for inj 30 mg/mL
Packing/Price
1 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in